Fujii H, Suzuki Y, Sawada K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: a large-scale multicenter retrospective study. Hepatol Res. 2023;53:1059–72.
Article CAS PubMed Google Scholar
Higuchi M, Tamaki N, Kurosaki M, et al. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022;55:292–301.
Nabi O, Lacombe K, Boursier J, et al. Prevalence and risk factors of nonalcoholic fatty liver disease and advanced fibrosis in general population: the French nationwide NASH-CO study. Gastroenterology. 2020;159:791-793.e2.
Article CAS PubMed Google Scholar
Nabi O, Lapidus N, Boursier J, et al. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology. 2023;78:272–83.
Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47:16–25.
Article CAS PubMed Google Scholar
Lu FB, Hu ED, Xu LM, et al. The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12:491–502.
Article CAS PubMed Google Scholar
Young S, Tariq R, Provenza J, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4:953–72.
Article CAS PubMed PubMed Central Google Scholar
Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040. Hepatol Int. 2021;15:366–79.
Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739–52.
Leung JC, Loong TC, Wei JL, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54–64.
Article CAS PubMed Google Scholar
Zou B, Yeo YH, Nguyen VH, et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016. J Intern Med. 2020;288:139–51.
Article CAS PubMed Google Scholar
Golabi P, Paik JM, Arshad T, et al. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun. 2020;4:1136–48.
Article CAS PubMed PubMed Central Google Scholar
Younes R, Govaere O, Petta S, et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2022;71:382–90.
Article CAS PubMed Google Scholar
Hagström H, Nasr P, Ekstedt M, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2:48–57.
Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.
Article CAS PubMed Google Scholar
Nakano M, Kawaguchi M, Kawaguchi T. almost identical values of various noninvasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia. J Hepatol. 2024;80:e155–7.
Nagai K, Tanaka T, Kodaira N, et al. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22:118–27.
Article PubMed PubMed Central Google Scholar
Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
Article PubMed PubMed Central Google Scholar
Mori K, Tanaka M, Higashiura Y, et al. High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. Hepatol Res. 2022;52:687–98.
Article CAS PubMed Google Scholar
Koehler EM, Schouten JN, Hansen BE, et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11:1201–4.
Fujihara K, Yamada-Harada M, Matsubayashi Y, et al. Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf. 2021;30:594–601.
Spreeuwenberg MD, Bartak A, Croon MA, et al. The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health. Med Care. 2010;48:166–74.
Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44–8.
Article CAS PubMed Google Scholar
Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. J Gastroenterol. 2015;50:95–108.
Article CAS PubMed Google Scholar
Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593–602.
Article CAS PubMed Google Scholar
Tang A, Ng CH, Phang PH, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs. non-lean NAFLD—a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:1750-1760.e12.
Article CAS PubMed Google Scholar
Ishido S, Tamaki N, Takahashi Y, et al. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease. BMC Gastroenterol. 2023;23:211.
Article CAS PubMed PubMed Central Google Scholar
Ha J, Yim SY, Karagozian R. Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:2496-2507.e5.
Chang Y, Cho YK, Cho J, et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study. Am J Gastroenterol. 2019;114:620–9.
Karagozian R, Bhardwaj G, Wakefield DB, et al. Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis. Liver Int. 2016;36:1450–6.
Kim D, Wijarnpreecha K, Sandhu KK, et al. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41:1832–40.
Article CAS PubMed Google Scholar
Kawanaka M, Nishino K, Kawada M, et al. Lean nonalcoholic fatty liver disease: age-dependent differences in pathology, prognosis, and liver-related events. Hepatol Res. 2023;53:829–43.
Article CAS PubMed Google Scholar
Iwaki M, Kobayashi T, Nogami A, et al. Impact of sarcopenia on non-alcoholic fatty liver disease. Nutrients. 2023;15:891.
Article CAS PubMed PubMed Central Google Scholar
Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471–7.
Article CAS PubMed Google Scholar
Ajmera V, Liu A, Bettencourt R, et al. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Aliment Pharmacol Ther. 2021;54:68–77.
Article CAS PubMed PubMed Central Google Scholar
Vilarinho S, Ajmera V, Zheng M, et al. Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD. Hepatology. 2021;74:2241–50.
Yip TC, Vilar-Gomez E, Petta S, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology. 2023;77:1404–27.
Tamaki N, Ahlholm N, Luukkonen PK, et al. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022;132:e162513.
留言 (0)